Gilmore Neil O'Neill
Director, CEO · 4 filings · Latest: Sep 3, 2026
Editas Medicine, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
EDIT | Gilmore Neil O'Neill | Director, CEO | Sep 3, 2026 | Sale | $3.04 | 5,124 | $15.6K | 243,189 | |
EDIT | O'Neill Gilmore Neil | — | Sep 3, 2026 | Proposed Sale | $3.28 | 5,100 | $16.7K | — | |
EDIT | Gilmore Neil O'Neill | Director, CEO | Jun 3, 2026 | Sale | $2.70 | 15,380 | $41.5K | 248,313 | |
EDIT | O'Neill Gilmore Neil | — | Jun 3, 2026 | Proposed Sale | $3.08 | 15,000 | $46.2K | — | |
EDIT | Gilmore Neil O'Neill | Director, CEO | Mar 3, 2026 | Sale | $2.02 | 5,394 | $10.9K | 263,693 | |
EDIT | O'Neill Gilmore Neil | — | Mar 3, 2026 | Proposed Sale | $1.89 | 6,000 | $11.3K | — | |
EDIT | O'Neill Gilmore Neil | — | Dec 3, 2025 | Proposed Sale | $2.50 | 7,000 | $17.5K | — | |
EDIT | O'Neill Gilmore Neil | — | Sep 3, 2025 | Proposed Sale | $2.73 | 7,000 | $19.1K | — | |
EDIT | O'Neill Gilmore Neil | — | Jun 3, 2025 | Proposed Sale | $1.87 | 20,000 | $37.4K | — | |
EDIT | O'Neill Gilmore Neil | — | Mar 3, 2025 | Proposed Sale | $1.86 | 35,000 | $65.1K | — | |
EDIT | O'Neill Gilmore Neil | — | Sep 3, 2024 | Proposed Sale | $3.92 | 3,000 | $11.8K | — |